Work

Scientific recommendations for a Belgian Sepsis National Action Plan (Be-SNAP)

Year: 2024
Type: report
Abstract: Sepsis is a life-threatening medical condition that occurs when the body's response to an infection causes intense inflammation, leading to dysfunction and failure of vital organs and functions, such as the kidneys, liver, heart, the brain or the blood clotting system. Sepsis and septic shock are associated with high mortality and substantial, long lasting morbidity. Depending on the location and population studied, about 10–30% of patients with sepsis die from the condition, with hospital mortality for septic shock approaching 40–60%. A wide variety of microorganisms may trigger sepsis, including bacteria, fungi, viruses, and parasites, depending on the region and setting where the infection occurs: at home (‘community-acquired’), during or shortly after a stay in the hospital or in a long term care facility (‘health care associated’). Sepsis can present in many settings and in a wide variety of patients, and is easily missed in its early stages. There is no single laboratory or imaging test to unequivocally confirm the diagnosis of sepsis, which is made based on a combination of clinical findings and laboratory tests (i.e. suspicion of infection plus signs of organ failure). Cultures of blood and other body samples are used to determine the causal pathogen and guide antimicrobial treatment. Sepsis can occur to anyone, but certain groups have particular risk: the very young and very old, pregnant women, persons with severe underlying co-morbidity and/or immune deficiency, persons who were recently admitted in hospital and/or have indwelling devices (e.g. vascular or urinary catheters), persons who survived earlier sepsis episodes, persons with severe underlying mental health, persons with limited education and/or precarious living circumstances (e.g. homeless, living in poverty, prisoners,…). Global estimates mention yearly about 50 million cases of sepsis, leading to at least 11 million deaths, of which the majority occurs in low and middle income settings. However, also Europe and other high income settings have an increasing sepsis burden in its ageing and increasingly vulnerable population and the emergence of antimicrobial resistance. There are very few surveillance data on sepsis and on its impact available for Belgium. According to estimates based on the 2017 Global Burden of Diseases study and other literature, there are about 40,952 sepsis cases every year in Belgium (95% CI 31,938 - 54,451), equal to an estimated incidence of 358/100,000 population (279-477/100,000 population), leading to 7,675 (95% CI 6,421-9,089) premature deaths per year, and associated to an annual loss of 38106 QALYs (47% of which through premature mortality), and an annual cost between €277 million and €4.3 billion, depending on the method used. In 2017, sepsis has been declared a priority for global health by the World Health Assembly (WHA). The WHA resolution on sepsis (WHA70.7) urges the member states to take action in developing and implementing national strategies to improve prevention, diagnosis and management of sepsis. Until date, there is no national sepsis plan nor coordinated action on the prevention and mitigation of the sepsis burden. Upon request of minister Frank Vandenbroucke, a multidisciplinary working group was set up in December 2023, with the mandate to deliver a scientific report within 4-6 months, that should be the fundament of a future national sepsis plan. The working group was created with representatives of various scientific professional organizations (including emergency medicine, primary care, nursing, infectious diseases and microbiology, intensive care, gerontology, pediatrics, rehabilitation,…), public health actors (e.g. Sciensano, regional and federal public health staff), sepsis researchers and representatives of the sepsis survivors patient organizations. Seven main themes were identified as the major fields requiring interventions to reduce the incidence and impact of sepsis in Belgium: 1. Awareness and knowledge 2. Prevention of sepsis and safeguarding effectiveness of antimicrobials (IPC and AMS) 3. Early warning systems 4. Early adequate treatment 5. Care trajectory for sepsis survivors 6. Strengthen advanced care planning 7. Research agenda and surveillance Each working group searched and summarized the available literature (with focus on systematic review), and formulated recommendations, which were discussed in two plenary sessions. For the final set of recommendations, an additional assessment of feasibility, cost and other implementation characteristics was carried out, with particular attention for the interface and synergism with already existing activities, plans and regulations (e.g. NAP-AMR, advanced care planning,…). The first version of this document (Version 30052024) will be delivered to minister Vandenbroucke on 31/05/2024, awaiting the feedback of external reviewers.
Authors: Brys, Astrid, Verthé, Cindy, Duval, Els, Verbakel, Jan, Van Bever, Jolien, Morreel, Stefan, Snoeij, Thomas, Malfait, Ilse, Merchie, An, Caluwaerts, Ann, Meex, Cécile, Bogaerts, Emilie, Coppens, Emilie, Repetto, Ernestina, Van Kersschaever, Greet, Masson, Hanna, Theeten, Heidi, Jansens, Hilde, Demunck, Jo, Chermais, Monia, Layios, Nathalie, Depuydt, Pieter, Cartuyvels, Reinoud, De Vos, Thomas, Cossey, Veerle, Vlieghe, Erika
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7052581883
Cites: 418
Cited by: 2
Related to: 10